Metformin showed promise for improving the overall survival rate of patients with melanoma; however, this result may be an ...

Congress, convening virtually and in Madrid, Spain, from June 13-16, 2024, will feature practice-changing findings in ...

Uninsured rates among minority groups plummeted between 2010 and 2022; Democrat lawmakers are challenging drug patents that ...

Amit Singal, MD, medical director of the Liver Tumor Program at UT Southwestern Medical Center, discussed the current outlook ...

Coverage from the 2024 American Society of Clinical Oncology Annual Meeting. Updates about antibody-drug conjugates (ADCs) ...

There may be a causal relaPatients with hyperthyroidism are at increased risk of ovarian cancer (OC), although the link ...

These findings suggest that a personalized approach should be implemented to better optimize treatments and manage a patient’s care journey. This retrospective cohort study is published in ...

Several experts that we spoke with for ASCO 2024 share their thoughts on why the American Society of Clinical Oncology annual meeting is so important to the field of oncology. For our coverage of ASCO ...

Speakers at SLEEP 2024, the annual meeting of The American Academy of Sleep Medicine and Sleep Research Society, share their favorite parts of the conference. At SLEEP 2024, the annual meeting of The ...

Surya Bhatt, MD, MSPH, of the University of Alabama at Birmingham, explained the phase 3 BOREAS and NOTUS trials demonstrated comparable safety profiles for dupilumab in treating patients with chronic ...

Respiratory syncytial virus (RSV) hospitalization–related features may help inform prevention approaches among children with ...

Tumor necrosis factor (TNF) inhibitor use was associated with a lower risk of cardiovascular outcomes in patients with ...